Algeta Schedules Third Quarter 2013 Results Presentation, Webcast and Conference Call
(Thomson Reuters ONE) -
Oslo, Norway, 28 October 2013 - Algeta ASA (OSE: ALGETA), a company focused on
the development of novel targeted cancer therapeutics, will announce its third
quarter 2013 results on Wednesday, 6 November 2013. A presentation by members of
Algeta's executive management team to investors, analysts and the press will
take place in Oslo at 10:00 CET.
The presentation will also be webcast live and can be accessed through
www.algeta.com where questions can also be submitted during the presentation.
The presentation will take place at 10:00 CET at:
KS-Agenda Møtesenter
Haakon VIIs gate 9
0161 Oslo
Norway.
At 14:30 CET/08:30 Eastern Time, Algeta's executive management team will also
host an international conference call.
To participate in the conference call, please dial the appropriate number below
five minutes prior to the call:
US: +1 877 423 0830
UK: +44 20 7153 9154
Norway: +47 21 06 61 13
Sweden: +46 8-506 443 86
Denmark: +45 32 71 42 62
Switzerland: +41 44 580 65 22
Participant pin code: 873878#
To access the replay, please dial:
US: +1 877 679 2989
UK: +44 203 364 5200
Norway: +47 23 50 02 03
Sweden: +46 8-505 564 73
Conference reference: 348995#
A replay of the conference call will also be available at www.algeta.com.
The results report and the presentation will be available at www.algeta.com in
the Investors section from 07:00 CET.
###
For further information, please contact:
Mike Booth +1 646 410 1884
Communications & Corporate Affairs ir(at)algeta.com
Media enquiries:
Mark Swallow +44 207 638 9571
Citigate Dewe Rogerson mark.swallow(at)citigatedr.co.uk
Knut Ekern +47 22 04 82 00
Gambit Hill & Knowlton knut.ekern(at)hkstrategies.com
Kari Watson +1 781 235 3060
MacDougall Biomedical Communications kwatson(at)macbiocom.com
Investor enquiries:
Tricia Truehart +1 646 378 2953
The Trout Group ttruehart(at)troutgroup.com
About Algeta
Algeta is a company focused on developing, manufacturing and marketing novel
targeted therapies for patients with cancer. The Company is headquartered in
Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA
performing commercial marketing operations in the US. Algeta is listed on the
Oslo Stock Exchange (Ticker: ALGETA). For more information please visit
www.algeta.com.
This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
Press release:
http://hugin.info/134655/R/1738455/583159.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Algeta ASA via Thomson Reuters ONE
[HUG#1738455]
Unternehmensinformation / Kurzprofil:
Datum: 28.10.2013 - 07:00 Uhr
Sprache: Deutsch
News-ID 309657
Anzahl Zeichen: 3900
contact information:
Town:
Oslo
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 121 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Algeta Schedules Third Quarter 2013 Results Presentation, Webcast and Conference Call"
steht unter der journalistisch-redaktionellen Verantwortung von
Algeta ASA (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
